Table 2 Mortality and clinical, radiographic, and global responses at Week 6

Mortality, n (mortality rate,^a %)

54 (22.8)

31 (20.3)

Asian subpopulation

n = 60

n = 37

 Mortality, n (mortality rate,^a %)

14 (23.9)

8 (22.2)

Non-Asian subpopulation

n = 180

n = 118

 Mortality, n (mortality rate,^a %)

40 (22.5)

23 (19.8)

Clinical responses, n^b (%)

n = 177

n = 88

 Complete (sign/symptom resolution)

105 (59.3)

42 (47.7)

 Partial (clinical improvement)

39 (22.0)

18 (20.5)

 Stable (no discernible change)

15 (8.5)

7 (8.0)

 Failure (worsening of signs/symptoms)

7 (4.0)

4 (4.5)

Radiographic responses, n^c (%)

n = 177

n = 88

 Complete (> 90% radiographic improvement)

35 (19.8)

22 (25.0)

 Partial (50–90% radiographic improvement)

81 (45.8)

34 (38.6)

 Stable (< 50% radiographic improvement)

37 (20.9)

10 (11.4)

 Failure (worsening disease)

12 (6.8)

5 (5.7)

Global responses,^d n (%)

n = 240

n = 155

 Complete

20 (8.3)

11 (7.1)

 Partial

73 (30.4)

15 (9.7)

 Stable

39 (16.3)

8 (5.2)

 Failure

13 (5.4)

4 (2.6)